ADVERSE DRUG REACTION
Rhabdomyolysis with atorvastatin and fusidic acid
1 The Heart Hospital, London, UK
2 Royal Surrey County Hospital, Guildford, Surrey, UK
3 Department of Neurophysiology, Whittington Hospital, London, UK
Correspondence to:
Dr C OMahony, The Heart Hospital, 16–18 Westmoreland Street, London W1G 8PH, UK; c.omahony{at}doctors.org.uk
Rhabdomyolysis is a rare but life-threatening complication of statin therapy. A 74-year-old man, treated with atorvastatin, developed rhabdomyolysis after the co-administration of fusidic acid and flucloxacillin. The patient recovered with supportive treatment and subsequently tolerated reintroduction of atorvastatin. Pharmacokinetic interactions can cause raised plasma statin concentrations, which can precipitate rhabdomyolysis in the presence of certain predisposing biological factors.
Keywords: rhabdomyolysis; fusidic acid; flucloxacillin; atorvastatin; statins
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Herring, R., Caldwell, G., Wade, S.
(2009). Rhabdomyolysis caused by an interaction of simvastatin and fusidic acid. BMJ Case Reports
2009: bcr0320091722-bcr0320091722
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
